— Know what they know.
Not Investment Advice

DECN OTC

Decision Diagnostics Corp.
1W: -99.0% 1M: -99.0% 3M: -99.0% YTD: -99.0% 1Y: -99.0% 3Y: -99.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±8124.6%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 58 · $35787 mcap · 380M float · 0.439% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$2M -16.8% ▼
5Y CAGR: +46.6%
Gross Profit
$498K -41.4% ▼
5Y CAGR: +24.1%
Operating Income
-$2M -63.1% ▼
Net Income
-$30M -847.2% ▼
EPS (Diluted)
$-0.11 -428.8% ▼
EBITDA
-$2M -1960.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2016FY2017FY2018FY2019FY2020
Revenue$725K$2M$2M$2M$2M
YoY Growth+148.4%+159.2%+18.9%+6.4%-16.8%
Cost of Revenue$477K$2M$2M$2M$1M
Gross Profit$249K-$70K$307K$850K$498K
Gross Margin34.3%-3.7%13.7%35.7%25.2%
R&D Expenses$0$0$0$0$0
SG&A Expenses$3M$2M$2M$2M$2M
Operating Expenses$3M$2M$2M$2M$3M
Operating Income-$3M-$2M-$2M-$1M-$2M
Operating Margin-361.9%-125.7%-82.9%-54.4%-106.7%
Interest Expense$0$350K$386K$3M$27M
Income Before Tax-$3M-$3M-$2M-$3M-$30M
Tax Expense$2K$2K$70$0$0
Net Income-$3M-$3M-$2M-$3M-$30M
Net Margin-409.0%-159.1%-100.2%-131.7%-1499.1%
EPS (Diluted)$-0.04$-0.03$-0.02$-0.02$-0.11
EBITDA$1M-$3M-$2M-$117K-$2M
Shares Outstanding66M94M125M150M267M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms